EU taxonomy OpEx disclosure
|
Financial year 2025 |
Sustantial contribution criteria |
Does Not Significantly Harm criteria |
|||||||||||||||||
|
Economic activities |
Code |
OpEx (Meuro) |
Proportion of OpEx 2025 (%) |
Climate change mitigation |
Climate change adaptation |
Water |
Circular economy |
Pollution |
Biodiversity |
Climate change mitigation |
Climate change adaptation |
Water |
Circular economy |
Pollution |
Biodiversity |
Minimum safeguards |
Proportion of Taxonomy-aligned (A.1.) or eligible (A.2.) OpEx, 2024 |
Category (transitional activity) |
Category (transitional activity) |
|
A. Taxonomy eligible activities |
|||||||||||||||||||
|
A.1. Environmentally sustainable activities (Taxonomy-aligned) |
|||||||||||||||||||
|
OpEx of environmentally sustainable activities (Taxonomy-aligned) (A.1) |
- |
0% |
0% |
||||||||||||||||
|
Of which enabling |
- |
0% |
0% |
E |
|||||||||||||||
|
Of which transitional |
- |
0% |
0% |
T |
|||||||||||||||
|
A.2. Taxonomy-eligible but not environmentally sustainable activities (not Taxonomy-aligned activities) |
|||||||||||||||||||
|
Manufacture of plastics in primary form1 |
CCM 3.17 |
5.1 |
5.4% |
EL |
N/EL |
N/EL |
N/EL |
N/EL |
N/EL |
4.7% |
|||||||||
|
Manufacture of active pharmaceutical ingredients (API) or active substances2 |
PPC 1.1 |
0.1 |
0.2% |
N/EL |
N/EL |
N/EL |
N/EL |
EL |
N/EL |
0.1% |
|||||||||
|
Construction, extension and operation of water collection, treatment and supply systems3 |
CCM 5.1 |
1.0 |
1.1% |
EL |
N/EL |
N/EL |
N/EL |
N/EL |
N/EL |
0.9% |
|||||||||
|
OpEx of taxonomy-eligible but not environmentally sustainable activities (not taxonomy-aligned activities) (A.2) |
6.2 |
6.6% |
6.5% |
0% |
0% |
0% |
0.2% |
0% |
5.7% |
||||||||||
|
Total (A1+A2) |
6.2 |
6.6% |
6.5% |
0% |
0% |
0% |
0.2% |
0% |
5.7% |
||||||||||
|
B. Taxonomy-non-eligible activities |
|||||||||||||||||||
|
OpEx of Taxonomy-non-eligible activities (B) |
87.4 |
93.4% |
|||||||||||||||||
|
Total (A+B)4 |
93.6 |
100.0% |
|||||||||||||||||